A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

Высоко консервативный скрытый эпитоп в рецепторсвязывающих доменах SARS-CoV-2 и SARS-CoV
Ian A. Wilson, Nicholas C. Wu, Meng Yuan, Xueyong Zhu, Chang-Chun David Lee, Ray T. Y. So, Huibin Lv, Chris Ka Pun Mok
2020-04-03

CR3022 antibodySARS-CoV-2 and SARS-CoV cross-reactivitycryptic epitopereceptor binding domain
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has now become a pandemic, but there is currently very little understanding of the antigenicity of the virus. We therefore determined the crystal structure of CR3022, a neutralizing antibody previously isolated from a convalescent SARS patient, in complex with the receptor binding domain (RBD) of the SARS-CoV-2 spike (S) protein at 3.1-angstrom resolution. CR3022 targets a highly conserved epitope, distal from the receptor binding site, that enables cross-reactive binding between SARS-CoV-2 and SARS-CoV. Structural modeling further demonstrates that the binding epitope can only be accessed by CR3022 when at least two RBDs on the trimeric S protein are in the "up" conformation and slightly rotated. These results provide molecular insights into antibody recognition of SARS-CoV-2.
1
CR3022 targets a highly conserved epitope on the RBD that is distal from the ACE2 receptor binding site.
2
Crystal structure of neutralizing antibody CR3022 bound to SARS-CoV-2 RBD was determined at 3.1 Å resolution.
3
Findings provide molecular insights into antibody recognition of SARS-CoV-2, informing antigenicity understanding.
4
Structural modeling shows CR3022 can access its epitope only when at least two RBDs in the trimeric spike are in the 'up' conformation and slightly rotated.
5
The conserved epitope enables cross-reactive binding between SARS-CoV-2 and SARS-CoV.

Receptor binding domain (RBD) of the SARS-CoV-2 spike protein in complex with the neutralizing antibody CR3022

Structure and antigenic epitope targeted by CR3022, specifically a highly conserved cryptic epitope enabling cross-reactive binding between SARS-CoV-2 and SARS-CoV and its accessibility dependent on RBD 'up' conformations in the trimeric S protein

Publication Details
Publication Date
2020-04-03
Journal
Publisher
ISSN
Cited by
1490
Access Type
Author Information
Authors
Ian A. Wilson
Nicholas C. Wu
Meng Yuan
Xueyong Zhu
Chang-Chun David Lee
Ray T. Y. So
Huibin Lv
Chris Ka Pun Mok
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%